|
Volumn 25, Issue 3, 1998, Pages 397-406
|
Gene therapy for ovarian carcinoma
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTOSINE DEAMINASE;
DEOXYRIBONUCLEOSIDE;
FLUCYTOSINE;
GANCICLOVIR;
PURINE NUCLEOSIDE PHOSPHORYLASE;
THYMIDINE KINASE;
VIRUS VECTOR;
ADENOVIRUS;
CARCINOGENESIS;
CLINICAL PROTOCOL;
COLORECTAL CANCER;
CYSTIC FIBROSIS;
ENZYME DEFICIENCY;
FAMILIAL POLYPOSIS;
FEMALE;
GENE THERAPY;
HERPES SIMPLEX VIRUS;
HUMAN;
IMMUNOPOTENTIATION;
MULTIDRUG RESISTANCE;
ONCOGENE NEU;
OVARY CARCINOMA;
PRIORITY JOURNAL;
REVIEW;
TUMOR SUPPRESSOR GENE;
BIOLOGICAL RESPONSE MODIFIERS;
DRUG RESISTANCE, MULTIPLE;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
HUMANS;
IMMUNOTHERAPY;
MUTAGENESIS;
OVARIAN NEOPLASMS;
PRODRUGS;
|
EID: 0031745609
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (26)
|
References (110)
|